Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Ulta Beauty Stock Is Down Today. Now Could Be a Good Time to Buy.
This might be the profit opportunity you've been waiting for.
Magnite Director Paul Caine Sells 7,500 Shares for $187,500
Key PointsThe transaction involved the sale of 7,500 shares, which netted the executive $187,500.